Session » Healthcare Disparities in Rheumatology Poster (0594–0622)

Date: Sunday, November 7, 2021

Time: 8:30AM-10:30AM

Meeting: ACR Convergence 2021

8:30AM-10:30AM: Abstract Number: 0600

A Cohort Study of Retention in Ambulatory Lupus Care Among Medicare Patients with SLE-related Hospitalizations

8:30AM-10:30AM: Abstract Number: 0608

Adaptation of a Shared Decision-Making Tool for Early Rheumatoid Arthritis Treatment Decisions with Indigenous Patients

8:30AM-10:30AM: Abstract Number: 0611

Association of Area Deprivation Index and Practice Patterns of Medicare Part D Rheumatologists

8:30AM-10:30AM: Abstract Number: 0603

Barriers and Potential Solutions in the Recruitment and Retention of Older Patients in Clinical Trials – Lessons Learned from Six Large Multi-center Randomized Controlled Trials

8:30AM-10:30AM: Abstract Number: 0621

Case Series of IgG4-related Disease in African American Patients at Two Large Academic Centers

8:30AM-10:30AM: Abstract Number: 0609

Challenges of Caring for Patients with Inflammatory Arthritis Experiencing Homelessness: Preliminary (12- Month) Follow-up Observations and Identification of Certain Barriers to Care

8:30AM-10:30AM: Abstract Number: 0617

Concerns and Beliefs About COVID-19 Vaccination Among Racial and Ethnic Minority Patients with Rheumatic Disease

8:30AM-10:30AM: Abstract Number: 0598

Differences in Discoid Lupus Erythematosus Skin Lesion Distribution and Characteristics in Black and Non-Black Patients: A Retrospective Cohort Study

8:30AM-10:30AM: Abstract Number: 0604

Disparities in Burden of Disease in Patients with RA Across Racial and Ethnic Groups

8:30AM-10:30AM: Abstract Number: 0599

Effectiveness of a Provider Led Intervention on Medication Adherence in an Urban Lupus Clinic

8:30AM-10:30AM: Abstract Number: 0622

Ethnic Disparities in Giant-Cell Arteritis: A Clinical Comparison Among Caucasian and Hispanic Patients in the Inland Empire of Southern California

8:30AM-10:30AM: Abstract Number: 0610

Evaluating Patient No Show Rates to Rheumatology Appointments Across a Regional Healthcare System

8:30AM-10:30AM: Abstract Number: 0606

How Might We Care for Rheumatoid Arthritis (RA) Patients Unable to See a Rheumatologist And/or Use Certain of Our Medications? Proposed Preliminary Recommendations for RA Patients Who Don’t Meet Our Established Guidelines

8:30AM-10:30AM: Abstract Number: 0605

Impact of Area of Residence on Perceptions of Health and Disease Activity in Ethnic Minorities with Rheumatoid Arthritis in an Urban Setting

8:30AM-10:30AM: Abstract Number: 0620

Is There a Difference in Disease Activity Between Genders in Axial Spondyloarthritis? 6-year Longitudinal Data from a Large National Cohort

8:30AM-10:30AM: Abstract Number: 0595

Lupus Nephritis Disparities Amongst Hospitalizations in the United States: A National Inpatient Sample Study

8:30AM-10:30AM: Abstract Number: 0618

Post-acute Sequelae of SARS-CoV-2 and Serological Response in a Cohort of Patients with Rheumatic Diseases

8:30AM-10:30AM: Abstract Number: 0616

Race and Socioeconomic Status and COVID-19 Outcomes in Patients with Rheumatic Diseases: Findings from a Tertiary Care Center in the Deep South

8:30AM-10:30AM: Abstract Number: 0619

Racial and Ethnic Disparities in Pregnancy Outcomes Among Women with Rheumatic Diseases: A Systematic Literature Review and Quantitative Analysis

8:30AM-10:30AM: Abstract Number: 0601

Racial Differences in Medication Beliefs Among SLE Patients

8:30AM-10:30AM: Abstract Number: 0596

Racial Disparities in US Adults with Systemic Lupus Erythematosus: Prevalence, Quality of Life, Comorbidities and Healthcare Costs

8:30AM-10:30AM: Abstract Number: 0613

Racial/Ethnic Disparities in Prescription Medications in a Large Urban Medical Center

8:30AM-10:30AM: Abstract Number: 0612

Rheumatology Care for the Underserved in Central Texas

8:30AM-10:30AM: Abstract Number: 0614

Sex and Race Based Utilization of Healthcare for Ocular Inflammation and Infection: Comparing the Results from the Medicare and the IRIS Data

8:30AM-10:30AM: Abstract Number: 0597

Sex Differences in Multimorbidity Between Patients with Systemic Lupus Erythematosus and Comparators in a Large Nationwide US Study

8:30AM-10:30AM: Abstract Number: 0615

Socioeconomic Characteristics Associated with Electronic Health Care Utilization in an Urban Rheumatology Clinic During the COVID-19 Pandemic

8:30AM-10:30AM: Abstract Number: 0594

The Burden of Systemic Lupus in Five Distinct Racial and Ethnic Groups in Israel: A Population-based Study

8:30AM-10:30AM: Abstract Number: 0602

Use of a Popular Opinion Leader Model to Disseminate Information Virtually About Clinical Trial Enrollment to People of Color with Lupus

8:30AM-10:30AM: Abstract Number: 0607

Validation Studies of Rheumatoid Arthritis Patient-Reported Outcome Measures in Diverse Populations at Risk for Inequity: A Systematic Review

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].